Sanuwave Health (SNWV)
NASDAQ:SNWV
Total Valuation
Sanuwave Health has a market cap or net worth of $151.26M. The enterprise value is $162.27M.
Market Cap$151.26M
Enterprise Value$162.27M
Share Statistics
Sanuwave Health has 8,594,209 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,594,209
Owned by Insiders27.60%
Owned by Institutions24.72%
Financial Efficiency
Sanuwave Health’s return on equity (ROE) is 7.30 and return on invested capital (ROIC) is 19.41%.
Return on Equity (ROE)7.30
Return on Assets (ROA)0.32
Return on Invested Capital (ROIC)19.41%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee957.63K
Profits Per Employee0.00
Employee Count46
Asset Turnover1.18
Inventory Turnover1.85
Valuation Ratios
The current PE Ratio of Sanuwave Health is 21.6. Sanuwave Health’s PEG ratio is -0.18.
PE Ratio21.6
PS Ratio5.80
PB Ratio157.84
Price to Fair Value157.84
Price to FCF132.13
Price to Operating Cash Flow36.57
PEG Ratio-0.18
Income Statement
In the last 12 months, Sanuwave Health had revenue of 44.05M and earned 11.81M in profits. Earnings per share was 1.38.
Revenue44.05M
Gross Profit33.09M
Operating Income4.95M
Pretax Income11.90M
Net Income11.81M
EBITDA6.23M
Earnings Per Share (EPS)1.38
Cash Flow
In the last 12 months, operating cash flow was 3.88M and capital expenditures 0.00, giving a free cash flow of 3.88M billion.
Operating Cash Flow3.88M
Free Cash Flow3.88M
Free Cash Flow per Share0.45
Dividends & Yields
Sanuwave Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-43.48%
50-Day Moving Average22.85
200-Day Moving Average31.12
Relative Strength Index (RSI)19.26
Average Volume (3m)78.76K
Important Dates
Sanuwave Health upcoming earnings date is May 8, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Sanuwave Health as a current ratio of 1.38, with Debt / Equity ratio of 1418.84%
Current Ratio1.38
Quick Ratio1.05
Debt to Market Cap0.09
Net Debt to EBITDA1.77
Interest Coverage Ratio0.79
Taxes
In the past 12 months, Sanuwave Health has paid 86.00K in taxes.
Income Tax86.00K
Effective Tax Rate<0.01
Enterprise Valuation
Sanuwave Health EV to EBITDA ratio is 42.80, with an EV/FCF ratio of 137.82.
EV to Sales6.05
EV to EBITDA42.80
EV to Free Cash Flow137.82
EV to Operating Cash Flow68.77
Balance Sheet
Sanuwave Health has $11.96M in cash and marketable securities with $22.97M in debt, giving a net cash position of -$11.01M billion.
Cash & Marketable Securities$11.96M
Total Debt$22.97M
Net Cash-$11.01M
Net Cash Per Share-$1.28
Tangible Book Value Per Share-$1.01
Margins
Gross margin is 75.12%, with operating margin of 11.23%, and net profit margin of 26.82%.
Gross Margin75.12%
Operating Margin11.23%
Pretax Margin27.01%
Net Profit Margin26.82%
EBITDA Margin14.14%
EBIT Margin11.23%
Analyst Forecast
The average price target for Sanuwave Health is $51.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$51.00
Price Target Upside62.94% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast40.89%
EPS Growth Forecast-749.65%